NL8301193A - Carbapenem antibiotica. - Google Patents

Carbapenem antibiotica. Download PDF

Info

Publication number
NL8301193A
NL8301193A NL8301193A NL8301193A NL8301193A NL 8301193 A NL8301193 A NL 8301193A NL 8301193 A NL8301193 A NL 8301193A NL 8301193 A NL8301193 A NL 8301193A NL 8301193 A NL8301193 A NL 8301193A
Authority
NL
Netherlands
Prior art keywords
carbon atoms
alkyl
group
groups
ring
Prior art date
Application number
NL8301193A
Other languages
English (en)
Dutch (nl)
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of NL8301193A publication Critical patent/NL8301193A/nl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
    • C07D477/16—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
    • C07D477/20—Sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NL8301193A 1982-04-08 1983-04-05 Carbapenem antibiotica. NL8301193A (nl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US36662782A 1982-04-08 1982-04-08
US36662782 1982-04-08

Publications (1)

Publication Number Publication Date
NL8301193A true NL8301193A (nl) 1983-11-01

Family

ID=23443823

Family Applications (1)

Application Number Title Priority Date Filing Date
NL8301193A NL8301193A (nl) 1982-04-08 1983-04-05 Carbapenem antibiotica.

Country Status (25)

Country Link
JP (1) JPS58188887A (sv)
KR (1) KR880001055B1 (sv)
AT (1) AT383126B (sv)
AU (1) AU567092B2 (sv)
BE (1) BE896407A (sv)
CA (1) CA1198440A (sv)
CH (1) CH661927A5 (sv)
DE (1) DE3312517A1 (sv)
DK (1) DK155983A (sv)
ES (1) ES8405399A1 (sv)
FI (1) FI74009C (sv)
FR (1) FR2524888B1 (sv)
GB (1) GB2118183B (sv)
GR (1) GR78822B (sv)
HU (1) HU190716B (sv)
IE (1) IE55225B1 (sv)
IL (1) IL68295A0 (sv)
IT (1) IT1168854B (sv)
LU (1) LU84739A1 (sv)
MY (1) MY8700945A (sv)
NL (1) NL8301193A (sv)
OA (1) OA07395A (sv)
PT (1) PT76518B (sv)
SE (1) SE460197B (sv)
ZA (1) ZA832411B (sv)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4683301A (en) * 1982-04-08 1987-07-28 Bristol-Myers Company Carbapenem antibiotics
US4552696A (en) * 1982-04-09 1985-11-12 Bristol-Myers Company Carbapenem antibiotics
US4536335A (en) * 1982-06-18 1985-08-20 Bristol-Myers Company Carbapenem antibiotics
AT396473B (de) * 1984-10-02 1993-09-27 Bristol Myers Squibb Co Verfahren zur herstellung von neuen carbapenemderivaten
US4665169A (en) * 1985-09-11 1987-05-12 Bristol-Myers Company Carbapenem antibiotics

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU531084B2 (en) * 1977-10-19 1983-08-11 Merck & Co., Inc. Azetidine derivatives
EP0017992A1 (en) * 1979-04-19 1980-10-29 Merck & Co. Inc. 2-Substituted-6-substituted-1-carbadethiapen-2-em-3-carboxylic acids, processes for preparing them, antibiotic pharmaceutical compositions containing same and process for preparing intermediates
EP0038869A1 (en) * 1980-04-30 1981-11-04 Merck & Co. Inc. Process for the preparation of 1-carbapenems, and intermediates for their preparation
HU185493B (en) * 1981-12-30 1985-02-28 Richter Gedeon Vegyeszet Process for producing new azabicyclo-bracket-3.2.0-bracket closedheptene derivatives
US4552696A (en) * 1982-04-09 1985-11-12 Bristol-Myers Company Carbapenem antibiotics
US4536335A (en) * 1982-06-18 1985-08-20 Bristol-Myers Company Carbapenem antibiotics

Also Published As

Publication number Publication date
GB2118183A (en) 1983-10-26
JPS58188887A (ja) 1983-11-04
BE896407A (fr) 1983-10-07
OA07395A (fr) 1984-06-30
IE55225B1 (en) 1990-07-04
FI74009C (sv) 1987-12-10
KR880001055B1 (ko) 1988-06-18
FI74009B (fi) 1987-08-31
SE8301928D0 (sv) 1983-04-07
GB8309505D0 (en) 1983-05-11
CH661927A5 (de) 1987-08-31
FI831135A0 (fi) 1983-04-05
DK155983A (da) 1983-10-09
ES521224A0 (es) 1984-06-01
FI831135L (fi) 1983-10-09
AU567092B2 (en) 1987-11-12
IT1168854B (it) 1987-05-20
DE3312517C2 (sv) 1991-10-31
DE3312517A1 (de) 1983-10-20
PT76518A (en) 1983-05-01
HU190716B (en) 1986-10-28
IE830800L (en) 1983-10-08
GB2118183B (en) 1985-11-27
MY8700945A (en) 1987-12-31
SE8301928L (sv) 1983-12-02
ES8405399A1 (es) 1984-06-01
FR2524888A1 (fr) 1983-10-14
CA1198440A (en) 1985-12-24
AU1319883A (en) 1983-10-13
SE460197B (sv) 1989-09-18
PT76518B (en) 1986-02-06
JPH0524156B2 (sv) 1993-04-06
FR2524888B1 (fr) 1985-12-13
ZA832411B (en) 1983-12-28
DK155983D0 (da) 1983-04-07
AT383126B (de) 1987-05-25
GR78822B (sv) 1984-10-02
KR840004429A (ko) 1984-10-15
IT8348061A0 (it) 1983-04-07
ATA125583A (de) 1986-10-15
LU84739A1 (fr) 1983-12-05
IL68295A0 (en) 1983-07-31

Similar Documents

Publication Publication Date Title
DE3321864C2 (sv)
AU630574B2 (en) 1-methylcarbapenem derivatives and process for preparation thereof
NL8301212A (nl) Carbapenemderivaten.
NL8301193A (nl) Carbapenem antibiotica.
GB2078220A (en) Penem-3-carboxylic acid derivatives and their preparation
DE3317742C2 (sv)
EP0235823B1 (en) Carbapenem antibiotics, a process for preparing them and pharmaceutical compositions containing them
KR910009270B1 (ko) 카바펜엠 항생제의 제조방법
AU598767B2 (en) Carbapenems with quaternized heterothioalkythio substitution at position 2
US4640799A (en) Carbapenem antibiotics
US4665170A (en) Carbapenem antibiotics
CS259892B2 (en) Method of 6-(1-hydroxyethyl)-7-oxo-1-azabiclo/3,2,o/hept-en-2-carboxyl acid's derivatives production
JPH0429675B2 (sv)
AT381942B (de) Verfahren zur herstellung neuer carbapenem-derivate
JP3037827B2 (ja) カルバペネム誘導体
AT396473B (de) Verfahren zur herstellung von neuen carbapenemderivaten
AT387388B (de) Verfahren zur herstellung von neuen carbapenem-antibiotika

Legal Events

Date Code Title Description
A85 Still pending on 85-01-01
BA A request for search or an international-type search has been filed
DNT Communications of changes of names of applicants whose applications have been laid open to public inspection

Free format text: BRISTOL-MYERS SQUIBB COMPANY

BB A search report has been drawn up
BC A request for examination has been filed
BV The patent application has lapsed